Pinch Grafting Versus Second Intention Wound Healing for Mohs Micrographic Surgery Defects on the Scalp
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Feb 23, 2024
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to help scalp wounds heal after surgery. One method allows the wounds to heal naturally on their own, which can take 8 weeks or longer. The other method is called "pinch grafting," where a doctor takes a small piece of skin from another part of the body (like the groin) and places it over the wound to help it heal faster. The trial aims to find out which method works better and helps wounds heal more quickly.
To be eligible for this study, participants need to be at least 18 years old, scheduled for a surgery on the scalp that is expected to heal on its own, and able to communicate in English. They should also be comfortable using MyChart, a patient portal where they can send weekly updates about their healing progress. Participants will be asked to return for follow-up visits and will have the chance to contribute to important research that could improve wound healing methods in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Able to give informed consent themselves
- • Patient scheduled for cutaneous surgical procedure on the scalp with predicted second intention closure
- • Willing to return for follow up visit
- • Active user of MyChart
- • Willing to send weekly messages until wound is healed
- Exclusion Criteria:
- • Incarceration
- • Under 18 years of age
- • Pregnant women
- • Unable to understand written and oral English
- • Scalp wounds with planned primary repair reconstruction
- • Surgical defects with bone exposure
- • No MyChart access or use
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Daniel Eisen, MD
Principal Investigator
University of California, Davis - Dermatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported